Back

Latest Forum Topics / Clearbridge    Last:0.002 --

Post Reply

Medical Stock - Strong Shareholders Post Reply Rate topic
churnw Elite	20-Jul-2020 21:45        churnw About Contact  Quote this Post!
x 0   x 0  Alert Admin	This is the only one not move ... at all Trader130      ( Date: 20-Jul-2020 21:32) Posted: CB spraying water now 😂 Zerocool888      ( Date: 20-Jul-2020 17:23) Posted: Hahahaha........this is a funny way to describe CB. CB uses turbo but the turbo has a very long lag. Goes up high and then few days later goes down like a waterfall.....
Useful To Me  Not Useful To Me
Trader130 Supreme	20-Jul-2020 21:32        Trader130 About Contact  Quote this Post!
x 0   x 0  Alert Admin	CB spraying water now 😂 Zerocool888      ( Date: 20-Jul-2020 17:23) Posted: Hahahaha........this is a funny way to describe CB. CB uses turbo but the turbo has a very long lag. Goes up high and then few days later goes down like a waterfall...... Sibehboeng      ( Date: 20-Jul-2020 17:09) Posted: All chiong with dohc turbo engine, only clrb still using sohc..
Useful To Me  Not Useful To Me
Zerocool888 Master	20-Jul-2020 17:23        Zerocool888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hahahaha........this is a funny way to describe CB. CB uses turbo but the turbo has a very long lag. Goes up high and then few days later goes down like a waterfall...... Sibehboeng      ( Date: 20-Jul-2020 17:09) Posted: All chiong with dohc turbo engine, only clrb still using sohc... churnw      ( Date: 20-Jul-2020 15:18) Posted: Today good vol ... all medical stock go up.
Useful To Me  Not Useful To Me
Sibehboeng Master	20-Jul-2020 17:09        Sibehboeng About Contact  Quote this Post!
x 0   x 0  Alert Admin	All chiong with dohc turbo engine, only clrb still using sohc... churnw      ( Date: 20-Jul-2020 15:18) Posted: Today good vol ... all medical stock go up.
Useful To Me  Not Useful To Me
churnw Elite	20-Jul-2020 15:18        churnw About Contact  Quote this Post!
x 0   x 0  Alert Admin	Today good vol ... all medical stock go up.
Useful To Me  Not Useful To Me
Trader130 Supreme	19-Jul-2020 21:17        Trader130 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Watch out for clearbridge  hotelgrand      ( Date: 19-Jul-2020 21:12) Posted: Clearbridge owns about 26% in Biolidics..latter has a company, Resolute was mentionrd in Sunday Tmes dated 19th July where test kits of COVID-19 can be cut from 4 hours to 2 hours..A* Star is working with a local medtech co to produce and deploy this test kit though no timeline was given.. I have 200lots of ckear bridge 17-18.6 cts always loaned out because pple have been shorting Clearbridge each time it moves near 20cts..my Clearbridge i am holding but signed.up.as marginal secuirities with CDP so from here can see many people shorting it to below 20cts but when to move nobody can stop its pent up.soaring especially when its subsidiary Biolidics soar past 60cts..hit 58cts recently.after trading halt lifted . Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will d
Useful To Me  Not Useful To Me
shadow11 Veteran	19-Jul-2020 21:16        shadow11 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Clearbridge bondholder cheeky. All convert at 0.14 to sell at market happily. Retailer hold babies
Useful To Me  Not Useful To Me
hotelgrand Master	19-Jul-2020 21:12        hotelgrand About Contact  Quote this Post!
x 0   x 0  Alert Admin	Clearbridge owns about 26% in Biolidics..latter has a company, Resolute was mentionrd in Sunday Tmes dated 19th July where test kits of COVID-19 can be cut from 4 hours to 2 hours..A* Star is working with a local medtech co to produce and deploy this test kit though no timeline was given.. I have 200lots of ckear bridge 17-18.6 cts always loaned out because pple have been shorting Clearbridge each time it moves near 20cts..my Clearbridge i am holding but signed.up.as marginal secuirities with CDP so from here can see many people shorting it to below 20cts but when to move nobody can stop its pent up.soaring especially when its subsidiary Biolidics soar past 60cts..hit 58cts recently.after trading halt lifted . Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will do Laurenpanna      ( Date: 17-Jul-2020 03:02) Posted: it ever went up to 0.35 before? I didn' t notice that. My average is 0.189 i bought intially at 0.21 , and then I average out at 0.169 . I would definitely hold. If tomorrow drop, i will grab mor
Useful To Me  Not Useful To Me
Laurenpanna Veteran	17-Jul-2020 10:36        Laurenpanna About Contact  Quote this Post!
x 0   x 0  Alert Admin	Yes, you are right too ! Thanks for the reminder. I should be very careful not to get into the FOMO feeling Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will do Laurenpanna      ( Date: 17-Jul-2020 03:02) Posted: it ever went up to 0.35 before? I didn' t notice that. My average is 0.189 i bought intially at 0.21 , and then I average out at 0.169 . I would definitely hold. If tomorrow drop, i will grab mor
Useful To Me  Not Useful To Me
Trader130 Supreme	17-Jul-2020 09:32        Trader130 About Contact  Quote this Post!
x 0   x 0  Alert Admin	I mean if already bought then just be it wait for the price go up then sell .. don' t ever averaging because u don' t know when the company can get delist .. just my honest advised ... Play with money that u can afford ... Don' t gamble  stanleytay      ( Date: 17-Jul-2020 08:24) Posted: what do u mean by stick to what u have to do? These medical counters are volatile.. if no stomach to play, better stay sidelines. Buy spore blue chips better.. all moving slowly Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will d
Useful To Me  Not Useful To Me
Trader130 Supreme	17-Jul-2020 09:26        Trader130 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Advised only ... just cash flow negeative double digits millions .. of no darlings , get prepare delists ..  stanleytay      ( Date: 17-Jul-2020 08:24) Posted: what do u mean by stick to what u have to do? These medical counters are volatile.. if no stomach to play, better stay sidelines. Buy spore blue chips better.. all moving slowly Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will d
Useful To Me  Not Useful To Me
Trader130 Supreme	17-Jul-2020 09:04        Trader130 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Skim milk   becarful 22investments      ( Date: 17-Jul-2020 08:42) Posted: Do search below to join our telegram group for penny stocks discussion.... sgxpennystocksdiscussion Everyone is welcome 👍 👍 👍 👍 🎉 🎉 !!!!
Useful To Me  Not Useful To Me
Shifu8888 Supreme	17-Jul-2020 08:24        Shifu8888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Agree. Should dip below 15 anytime Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will do Laurenpanna      ( Date: 17-Jul-2020 03:02) Posted: it ever went up to 0.35 before? I didn' t notice that. My average is 0.189 i bought intially at 0.21 , and then I average out at 0.169 . I would definitely hold. If tomorrow drop, i will grab mor
Useful To Me  Not Useful To Me
stanleytay Master	17-Jul-2020 08:24        stanleytay About Contact  Quote this Post!
x 0   x 0  Alert Admin	what do u mean by stick to what u have to do? These medical counters are volatile.. if no stomach to play, better stay sidelines. Buy spore blue chips better.. all moving slowly Trader130      ( Date: 17-Jul-2020 08:08) Posted: Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will do Laurenpanna      ( Date: 17-Jul-2020 03:02) Posted: it ever went up to 0.35 before? I didn' t notice that. My average is 0.189 i bought intially at 0.21 , and then I average out at 0.169 . I would definitely hold. If tomorrow drop, i will grab mor
Useful To Me  Not Useful To Me
Trader130 Supreme	17-Jul-2020 08:08        Trader130 About Contact  Quote this Post!
x 1   x 0  Alert Admin	Think better don' t accumulate .. the penny stock all very negative in their cash flow .. anytime can run with your money .. just stick to what u have will do Laurenpanna      ( Date: 17-Jul-2020 03:02) Posted: it ever went up to 0.35 before? I didn' t notice that. My average is 0.189 i bought intially at 0.21 , and then I average out at 0.169 . I would definitely hold. If tomorrow drop, i will grab more hotelgrand      ( Date: 16-Jul-2020 13:08) Posted: becoz bought high 35cts right? loss making co...can multi bagger meh? philip secuirities say so?
Useful To Me  Not Useful To Me
Laurenpanna Veteran	17-Jul-2020 03:02        Laurenpanna About Contact  Quote this Post!
x 0   x 0  Alert Admin	it ever went up to 0.35 before? I didn' t notice that. My average is 0.189 i bought intially at 0.21 , and then I average out at 0.169 . I would definitely hold. If tomorrow drop, i will grab more hotelgrand      ( Date: 16-Jul-2020 13:08) Posted: becoz bought high 35cts right? loss making co...can multi bagger meh? philip secuirities say so?? Laurenpanna      ( Date: 15-Jul-2020 14:11) Posted: this stock is going to be my long term hold for sure... hahahaha
Useful To Me  Not Useful To Me
Laurenpanna Veteran	17-Jul-2020 02:59        Laurenpanna About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hey brother, how much are you holding? If there is not much loss, i suggest you sell first. Otherwise you will be stressing yourself out. I can feel that you are really stress out. Faster exit the counter and buy other stock. Take cash is better. Nowadays cash is king xKaiseRx      ( Date: 17-Jul-2020 00:41) Posted: take a good look at biolidics announcement... lols to think u have so much faith in him xKaiseRx      ( Date: 16-Jul-2020 15:47) Posted: why people keep promoting his portfolio... you mean people who has previous good record cannot fail
Useful To Me  Not Useful To Me
xKaiseRx Veteran	17-Jul-2020 00:41        xKaiseRx About Contact  Quote this Post!
x 0   x 0  Alert Admin	take a good look at biolidics announcement... lols to think u have so much faith in him xKaiseRx      ( Date: 16-Jul-2020 15:47) Posted: why people keep promoting his portfolio... you mean people who has previous good record cannot fail? WBdisciple      ( Date: 16-Jul-2020 14:45) Posted: Really old article but it captures the leadership and foresight of Jeremy Yee (when he was CEO at Cordlife) https://www.forbes.com/sites/forbesasia/2015/06/24/cordlife-harvests-stem-cells-of-newborns-in-case-of-a-rare-disease/#abbccda43dca Cordlife Harvests Stem Cells Of Newborns In Case Of A Rare Disease This story appears in the July 2015 issue of Forbes Asia. Subscribe to Forbes Asia By Jane A. Peterson Walking down a hallway at the headquarters of Singapore health care company Cordlife, Chief Executive Jeremy Yee points to plaques commemorating 18 successful stem-cell infusions over its 14-year history. Georgia Conn' s cerebral palsy has improved after getting blood from her own umbilical cord when she was 2 years old. One 16-year-old is now in remission from leukemia, thanks to receiving his sister' s cord blood. " The odds of fighting off disease in a family are much higher if you store your own cord blood," says Yee. " Our strategy is to empower everyone to store."   Cordlife operates cord-blood banks in five countries and rallies expectant parents with the emotive tagline, " one chance, one choice." It' s like an insurance policy against a rare disease: The stem cells derived from the blood are used in transplants to combat certain types of cancer and blood disorders. But customers are looking beyond current medical uses as advances in stem-cell therapy continue apace. Researchers hope that one day cord blood will be used for a host of other conditions, such as diabetes, heart disease and stroke. " Our role as a custodian is very much like a bank," says cofounder Ho Choon Hou, a principal at Southern Capital Group, a Singapore private equity firm. Ho also chairs Cordlife' s board. In Singapore new parents can choose to have their child' s cord-blood stem cells stored for 21 years under a $4,450 plan that also includes collection and processing. Storing the umbilical-cord lining costs an additional $4,450. The plans can be renewed once the child reaches adulthood. Banking umbilical-cord blood has caught fire in Asia, and Cordlife is well-positioned to cash in. The company boasts more than 100,000 customers and 700 employees for the region' s largest network of cord-blood banks. Singapore and Hong Kong are its most developed markets, with India, Indonesia and the Philippines quickly advancing. It also has a stake in Malaysia' s StemLife Bhd., which gives the company indirect access to Thai StemLife. Investors are piling in. Cordlife' s shares on the Singapore Exchange are up 25% this year, and analysts continue to rate the company a buy. Net profits more than doubled to $24.2 million for the year ended June 30, 2014. Analysts forecast lower net profits for the year ended last month but also a 13% rise in revenue, to $43 million. With this performance Cordlife debuts on our list of the 200 best listed companies in the Asia-Pacific region with under $1 billion in annual revenue. The business has its skeptics, however. Several government health agencies and doctors' associations in the West doubt that storing cord blood is a good way for parents to spend their money. The U.K.' s National Health Service cautions that the " probability of an average child requiring a transplant of their own stem cells before the age of 20 is estimated at between one in 5,000 and one in 20,000." For leukemia, it states, the use of a child' s own cord blood is " extremely unlikely."   Intent on driving down costs as the business scales up, Yee champions a no-frills operation. An energetic, 45-year-old trained accountant, he' s Cordlife' s " longest surviving employee" --he joined in 2002. His own small office is tucked in among a hive of 110 employees on the sixth floor of a spartan building in the Yishun district. Steps from his office Yee peers through a window overlooking the lab. Here no expense is spared. Twice a day technicians receive deliveries of cord blood from hospitals around Singapore. They cull the maximum number of adult stem cells from each specimen, placing the CryoBags--marked and sealed--inside one of 15 temperature-controlled metal tanks, where they remain for the duration of the plan. Yee says the room could take 35 more. Similar operations exist across Cordlife' s Asian network. In India, where the charge for storing cord blood is far lower than in Singapore--$860 for an 18-year policy--Cordlife stores blood in Kolkata, has service centers in 42 cities and faces stiff competition. " Currently India is the largest contributor of new clients, though margins are lower," explains Yee, noting that volume jumped 50% in the fiscal year just ended. To capture more market share in India, Cordlife launched a pricey advertising campaign last year. While that hurt the bottom line, Yee believes that the awareness of parents required a jump start. Analysts liked the move. " It' s a one-off shot," says Conrad Werner at Macquarie Capital Securities. " Make a blitz and reap the reward. Next year we forecast a 46% jump in net profits."   This year Cordlife agreed to sell its stake in the Chinese cord-blood bank operator CCBC, mainly because that company may be taken private. The sale is expected to generate net proceeds of $65 million, money that could help Cordlife build a business in China from the ground up: " We will start organically now in China, licensing technologies to hospitals and launching new screening services," says Yee. " We hope it will be a huge share of our revenue stream."   Though Cordlife is now well-established, its startup days in 2001 were tough. Singaporeans had to be persuaded to save their children' s blood and to pay top dollar to do so. The venture was the brainchild of entrepreneur Steven Fang, a Singaporean who is no longer with the company. Fang sought venture capital funding for an Asian version of New York' s then-nine-year-old government cord-blood bank, while Ho focused on talking to regulators and doctors. In those early days the 21-year plan was pricier, but Cordlife still managed to sign up between 20 and 30 new mothers every month, stressing its promise of the highest-quality storage possible and its American Association of Blood Banks accreditation. " Our drive to transparency and [good] governance was key for us," recounts Ho, adding that this paved the way for the company to go public in 2012. Western parents rely less on private-sector cord-blood banks than do Asians. In the U.S. and Europe market-penetration rates for private banks hover at just 5% of all live births in Singapore it' s 22%, the lion' s share going to Cordlife rather than to its two competitors, while government banks get just a tiny percentage of the rest. " Asian parents invest an enormous amount in their children," says Ho, noting that Cordlife customers are the same ones who shower their offspring with extra schooling and extracurricular activities. So far the children of 18 customers--the 18 on the plaques--have had to use their stored cord blood. In India, Indonesia and the Philippines penetration rates are under 1%. However, analysts predict that they will rise as parents' awareness--and ability to pay--ratchets up. Cordlife' s " addressable sweet spot" is households with annual incomes of at least $50,000, ?according to Werner at Macquarie. For now Cordlife will hold off on opening offices and banks in more countries, choosing instead to build its key storage business in its existing markets and expand its range of services. But the company does want to sell more services to doctors and hospitals in other countries, including China. Yee cites plans to roll out at least five new mother/child products and services, which will focus on children up to age 7 among them, MetaScreen, a test of infants' urine that detects metabolic disorders. " I used to be afraid of the share price," admits Yee, " but after soul-searching I realized that is not the way. My endgame is to satisfy shareholders and be value-adding to humankind. I' m hot about that."
Useful To Me  Not Useful To Me
xKaiseRx Veteran	17-Jul-2020 00:11        xKaiseRx About Contact  Quote this Post!
x 0   x 0  Alert Admin	sure or not they say half yearly and full year reporting will still continue imma55      ( Date: 16-Jul-2020 11:54) Posted: Thanks for the info Acidrxz      ( Date: 16-Jul-2020 10:52) Posted: They revise alrdy chk sgx clearbridge....is half yearly...next results announcement only in NOV 202
Useful To Me  Not Useful To Me
xKaiseRx Veteran	16-Jul-2020 15:47        xKaiseRx About Contact  Quote this Post!
x 0   x 0  Alert Admin	why people keep promoting his portfolio... you mean people who has previous good record cannot fail? WBdisciple      ( Date: 16-Jul-2020 14:45) Posted: Really old article but it captures the leadership and foresight of Jeremy Yee (when he was CEO at Cordlife) https://www.forbes.com/sites/forbesasia/2015/06/24/cordlife-harvests-stem-cells-of-newborns-in-case-of-a-rare-disease/#abbccda43dca Cordlife Harvests Stem Cells Of Newborns In Case Of A Rare Disease This story appears in the July 2015 issue of Forbes Asia. Subscribe to Forbes Asia By Jane A. Peterson Walking down a hallway at the headquarters of Singapore health care company Cordlife, Chief Executive Jeremy Yee points to plaques commemorating 18 successful stem-cell infusions over its 14-year history. Georgia Conn' s cerebral palsy has improved after getting blood from her own umbilical cord when she was 2 years old. One 16-year-old is now in remission from leukemia, thanks to receiving his sister' s cord blood. " The odds of fighting off disease in a family are much higher if you store your own cord blood," says Yee. " Our strategy is to empower everyone to store."   Cordlife operates cord-blood banks in five countries and rallies expectant parents with the emotive tagline, " one chance, one choice." It' s like an insurance policy against a rare disease: The stem cells derived from the blood are used in transplants to combat certain types of cancer and blood disorders. But customers are looking beyond current medical uses as advances in stem-cell therapy continue apace. Researchers hope that one day cord blood will be used for a host of other conditions, such as diabetes, heart disease and stroke. " Our role as a custodian is very much like a bank," says cofounder Ho Choon Hou, a principal at Southern Capital Group, a Singapore private equity firm. Ho also chairs Cordlife' s board. In Singapore new parents can choose to have their child' s cord-blood stem cells stored for 21 years under a $4,450 plan that also includes collection and processing. Storing the umbilical-cord lining costs an additional $4,450. The plans can be renewed once the child reaches adulthood. Banking umbilical-cord blood has caught fire in Asia, and Cordlife is well-positioned to cash in. The company boasts more than 100,000 customers and 700 employees for the region' s largest network of cord-blood banks. Singapore and Hong Kong are its most developed markets, with India, Indonesia and the Philippines quickly advancing. It also has a stake in Malaysia' s StemLife Bhd., which gives the company indirect access to Thai StemLife. Investors are piling in. Cordlife' s shares on the Singapore Exchange are up 25% this year, and analysts continue to rate the company a buy. Net profits more than doubled to $24.2 million for the year ended June 30, 2014. Analysts forecast lower net profits for the year ended last month but also a 13% rise in revenue, to $43 million. With this performance Cordlife debuts on our list of the 200 best listed companies in the Asia-Pacific region with under $1 billion in annual revenue. The business has its skeptics, however. Several government health agencies and doctors' associations in the West doubt that storing cord blood is a good way for parents to spend their money. The U.K.' s National Health Service cautions that the " probability of an average child requiring a transplant of their own stem cells before the age of 20 is estimated at between one in 5,000 and one in 20,000." For leukemia, it states, the use of a child' s own cord blood is " extremely unlikely."   Intent on driving down costs as the business scales up, Yee champions a no-frills operation. An energetic, 45-year-old trained accountant, he' s Cordlife' s " longest surviving employee" --he joined in 2002. His own small office is tucked in among a hive of 110 employees on the sixth floor of a spartan building in the Yishun district. Steps from his office Yee peers through a window overlooking the lab. Here no expense is spared. Twice a day technicians receive deliveries of cord blood from hospitals around Singapore. They cull the maximum number of adult stem cells from each specimen, placing the CryoBags--marked and sealed--inside one of 15 temperature-controlled metal tanks, where they remain for the duration of the plan. Yee says the room could take 35 more. Similar operations exist across Cordlife' s Asian network. In India, where the charge for storing cord blood is far lower than in Singapore--$860 for an 18-year policy--Cordlife stores blood in Kolkata, has service centers in 42 cities and faces stiff competition. " Currently India is the largest contributor of new clients, though margins are lower," explains Yee, noting that volume jumped 50% in the fiscal year just ended. To capture more market share in India, Cordlife launched a pricey advertising campaign last year. While that hurt the bottom line, Yee believes that the awareness of parents required a jump start. Analysts liked the move. " It' s a one-off shot," says Conrad Werner at Macquarie Capital Securities. " Make a blitz and reap the reward. Next year we forecast a 46% jump in net profits."   This year Cordlife agreed to sell its stake in the Chinese cord-blood bank operator CCBC, mainly because that company may be taken private. The sale is expected to generate net proceeds of $65 million, money that could help Cordlife build a business in China from the ground up: " We will start organically now in China, licensing technologies to hospitals and launching new screening services," says Yee. " We hope it will be a huge share of our revenue stream."   Though Cordlife is now well-established, its startup days in 2001 were tough. Singaporeans had to be persuaded to save their children' s blood and to pay top dollar to do so. The venture was the brainchild of entrepreneur Steven Fang, a Singaporean who is no longer with the company. Fang sought venture capital funding for an Asian version of New York' s then-nine-year-old government cord-blood bank, while Ho focused on talking to regulators and doctors. In those early days the 21-year plan was pricier, but Cordlife still managed to sign up between 20 and 30 new mothers every month, stressing its promise of the highest-quality storage possible and its American Association of Blood Banks accreditation. " Our drive to transparency and [good] governance was key for us," recounts Ho, adding that this paved the way for the company to go public in 2012. Western parents rely less on private-sector cord-blood banks than do Asians. In the U.S. and Europe market-penetration rates for private banks hover at just 5% of all live births in Singapore it' s 22%, the lion' s share going to Cordlife rather than to its two competitors, while government banks get just a tiny percentage of the rest. " Asian parents invest an enormous amount in their children," says Ho, noting that Cordlife customers are the same ones who shower their offspring with extra schooling and extracurricular activities. So far the children of 18 customers--the 18 on the plaques--have had to use their stored cord blood. In India, Indonesia and the Philippines penetration rates are under 1%. However, analysts predict that they will rise as parents' awareness--and ability to pay--ratchets up. Cordlife' s " addressable sweet spot" is households with annual incomes of at least $50,000, ?according to Werner at Macquarie. For now Cordlife will hold off on opening offices and banks in more countries, choosing instead to build its key storage business in its existing markets and expand its range of services. But the company does want to sell more services to doctors and hospitals in other countries, including China. Yee cites plans to roll out at least five new mother/child products and services, which will focus on children up to age 7 among them, MetaScreen, a test of infants' urine that detects metabolic disorders. " I used to be afraid of the share price," admits Yee, " but after soul-searching I realized that is not the way. My endgame is to satisfy shareholders and be value-adding to humankind. I' m hot about that."
Useful To Me  Not Useful To Me

                                                         First   < Newer   1521-1540 of 4753   Older>   Last